CSIMarket
 
Pavmed Inc   (NASDAQ: PAVM)
 

Pavmed Inc's Customers Performance

PAVM



 
PAVM's Source of Revenues During the corresponding time, Pavmed Inc recorded a revenue increase by 135.71 % year on year, sequentially revenue fell by -36.54 %. While revenue at the Pavmed Inc 's corporate clients

List of PAVM Customers




for the same period Pavmed Inc recorded revenue increase by 135.71 % year on year, sequentially revenue fell by -36.54 %.

List of PAVM Customers

Pavmed Inc's Business Units






Pavmed Inc's Comment on Sales, Marketing and Customers



The company operates in the U.S. cancer patient care market, specializing in digital care platforms that include electronic health record (EHR) integration and remote patient monitoring. Its Veris Cancer Care Platform is classified as Non-Device Clinical Decision Software. The company is also developing an implantable physiological monitor. Additionally, it develops medical device technologies such as the PortIO implantable intraosseous vascular access device, designed for clinical settings including trauma and pediatric emergencies, and endoscopic imaging technology licensed exclusively from Duke University. The endoscopic technology features a multi-modality probe. Customers and partners mentioned in company filings include Duke University and Salesforce.





Pavmed Inc’s Comment on Sales, Marketing and Customers


The company operates in the U.S. cancer patient care market, specializing in digital care platforms that include electronic health record (EHR) integration and remote patient monitoring. Its Veris Cancer Care Platform is classified as Non-Device Clinical Decision Software. The company is also developing an implantable physiological monitor. Additionally, it develops medical device technologies such as the PortIO implantable intraosseous vascular access device, designed for clinical settings including trauma and pediatric emergencies, and endoscopic imaging technology licensed exclusively from Duke University. The endoscopic technology features a multi-modality probe. Customers and partners mentioned in company filings include Duke University and Salesforce.








PAVM's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Pavmed Inc 26.55 0.11 -22.16 41
SUBTOTAL 0.00 0.00 0.00 -

Sources: Pavmed Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pavmed Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pavmed Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.